1. Home
  2. KALA vs SNT Comparison

KALA vs SNT Comparison

Compare KALA & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • SNT
  • Stock Information
  • Founded
  • KALA 2009
  • SNT 1965
  • Country
  • KALA United States
  • SNT Canada
  • Employees
  • KALA N/A
  • SNT N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • SNT Telecommunications Equipment
  • Sector
  • KALA Health Care
  • SNT Telecommunications
  • Exchange
  • KALA Nasdaq
  • SNT Nasdaq
  • Market Cap
  • KALA 32.0M
  • SNT 36.6M
  • IPO Year
  • KALA 2017
  • SNT 1993
  • Fundamental
  • Price
  • KALA $6.48
  • SNT $3.03
  • Analyst Decision
  • KALA Strong Buy
  • SNT
  • Analyst Count
  • KALA 2
  • SNT 0
  • Target Price
  • KALA $15.00
  • SNT N/A
  • AVG Volume (30 Days)
  • KALA 33.2K
  • SNT 113.6K
  • Earning Date
  • KALA 11-12-2024
  • SNT 11-12-2024
  • Dividend Yield
  • KALA N/A
  • SNT N/A
  • EPS Growth
  • KALA N/A
  • SNT N/A
  • EPS
  • KALA N/A
  • SNT 0.06
  • Revenue
  • KALA N/A
  • SNT $34,455,000.00
  • Revenue This Year
  • KALA N/A
  • SNT N/A
  • Revenue Next Year
  • KALA N/A
  • SNT N/A
  • P/E Ratio
  • KALA N/A
  • SNT $49.70
  • Revenue Growth
  • KALA N/A
  • SNT 2.04
  • 52 Week Low
  • KALA $4.21
  • SNT $1.08
  • 52 Week High
  • KALA $10.97
  • SNT $3.15
  • Technical
  • Relative Strength Index (RSI)
  • KALA 49.93
  • SNT 85.10
  • Support Level
  • KALA $6.00
  • SNT $2.41
  • Resistance Level
  • KALA $7.85
  • SNT $3.15
  • Average True Range (ATR)
  • KALA 0.40
  • SNT 0.24
  • MACD
  • KALA -0.11
  • SNT 0.12
  • Stochastic Oscillator
  • KALA 29.19
  • SNT 88.48

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

Share on Social Networks: